STOCK TITAN

Canopy Growth Corp Stock Price, News & Analysis

CGC Nasdaq

Welcome to our dedicated page for Canopy Growth news (Ticker: CGC), a resource for investors and traders seeking the latest updates and insights on Canopy Growth stock.

Canopy Growth Corporation (CGC) generates a steady flow of news as a cannabis-focused manufacturer with operations spanning medical and adult-use markets, branded products, and vaporization devices. The Canopy Growth news page on Stock Titan aggregates these disclosures so readers can follow how the company’s strategy, financing, and operations evolve over time.

Company news frequently covers financial performance and capital structure. Canopy Growth issues quarterly results releases that discuss cannabis and Storz & Bickel net revenue, segment performance in Canada and international markets, gross margins, operating loss, adjusted EBITDA, and free cash flow, along with commentary on cost management and balance sheet strength. The company also announces financing transactions, such as term loan agreements, prepayments on senior secured debt, convertible debenture exchanges, and at-the-market equity programs.

Another major category of news involves corporate transactions and governance. Canopy Growth has reported entering into an arrangement agreement to acquire MTL Cannabis Corp., detailing consideration, required approvals, and expected strategic benefits. It also publishes results of its annual general and special meetings, including director elections, auditor appointments, share consolidation authority, and advisory votes on executive compensation, as well as updates on board and executive appointments.

Product and market updates are a recurring theme. The company announces launches such as Claybourne Gassers liquid diamonds All-in-One vapes and Claybourne Frosted Flyers infused pre-roll variety packs in Canada, along with expansions of the Spectrum Therapeutics medical portfolio in Australia through new softgel formats. It also highlights operational moves like dedicating the DOJA facility in Kelowna to medical cultivation for Spectrum Therapeutics patients.

Investors and observers who monitor CGC news can use this page to track developments in Canopy Growth’s Canadian adult-use and medical businesses, its international medical operations in Europe and Australia, its indirect exposure to the U.S. THC market through Canopy USA, and its ongoing efforts to manage debt, liquidity, and governance matters. Bookmark this feed to review new press releases, transaction updates, and regulatory communications as they are published.

Rhea-AI Summary

Canopy Growth (NASDAQ:CGC) has scheduled its first quarter fiscal 2026 financial results release for August 8, 2025, before market open. The company will host an audio webcast at 10:00 AM ET on the same day, featuring CEO Luc Mongeau and Interim CFO Tom Stewart.

The webcast will be available live and accessible for replay until November 6, 2025 at 11:59 PM ET through the company's online portal.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.7%
Tags
conferences earnings
-
Rhea-AI Summary

Canopy Growth (Nasdaq: CGC) has launched Deep Space Infused pre-rolls, combining high-quality flower with liquid diamonds and THCA diamonds to achieve THC levels above 60%. The product comes in a 3x0.5g format with two flavors: Milky Way Melon Infused and Big Bang Berry Infused.

The launch is part of Canopy's strategy to expand in the fast-growing pre-roll category, particularly in the infused segment. This follows recent Deep Space beverage and gummy innovations, building on the success of Claybourne's Frosted Flyers launched in November 2024.

The products are now available at licensed retailers across select regions in Canada, including the Spectrum Therapeutics online store for medical consumers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.56%
Tags
none
-
Rhea-AI Summary

Canopy Growth (Nasdaq: CGC) has appointed Tom Stewart as Interim Chief Financial Officer, effective immediately. Stewart, who joined the company in 2019 as Chief Accounting Officer, brings over 20 years of experience in operational finance and accounting leadership, including 10 years at Constellation Brands.

Stewart succeeds Judy Hong, who served as CFO since April 2022 and helped improve the company's capital structure. The appointment aligns with Canopy Growth's FY26 strategy, focusing on operational efficiency, disciplined capital management, and building a sustainable, performance-led business. The company has initiated a search for a permanent CFO.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.44%
Tags
management
Rhea-AI Summary

Storz & Bickel, a subsidiary of Canopy Growth Corporation (NASDAQ: CGC), has been awarded 'Equipment Provider of the Year' at the 2025 Business of Cannabis Awards during the Cannabis Europa conference in London.

The award recognizes the company's excellence in vaporization technology, highlighting products like the iconic VOLCANO tabletop vaporizer and the new VENTY device, which features 20-second heat-up and adjustable airflow up to 20 L/min. Storz & Bickel's vaporizers are available in over 120 countries and comply with ISO 13485 standards.

The company has also received multiple other recent accolades, including "Vaporizer of the Year" at The EMJAYs and "Best Portable Vaporizer" by Vaping360 for the VENTY device.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.5%
Tags
none
-
Rhea-AI Summary
Canopy Growth (CGC) reported Q4 FY2025 and full-year results showing mixed performance. Q4 net revenue decreased 11% YoY to $65M, while Canada cannabis revenue grew 4%, led by 13% growth in medical cannabis. The company reduced total debt by $293M (49%) during FY2025. Operating loss improved 83% to $18M in Q4, with Adjusted EBITDA loss improving 39% to $9M. The company implemented strategic changes including unifying global medical cannabis operations and identifying $20M in cost savings. Storz & Bickel revenue declined 23% in Q4 but grew 4% for the full year. International cannabis revenue fell 35% in Q4 due to regulatory challenges in Poland. Management is focused on achieving positive Adjusted EBITDA in the near term through growth in medical cannabis, improved margins in adult-use, and cost reductions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-22.81%
Tags
-
Rhea-AI Summary

Canopy Growth Corporation (NASDAQ: CGC) has announced it will release its fourth quarter and fiscal year 2025 financial results on May 30, 2025, before market open. Following the release, CEO Luc Mongeau and CFO Judy Hong will host an audio webcast at 10 AM ET. The webcast will be available for replay until August 28, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
23.88%
Tags
conferences earnings
Rhea-AI Summary

Canopy Growth (NASDAQ: CGC) has launched new cannabis products targeting Canada's highest-demand adult-use categories. The company is focusing on four key formats: vapes, high-THC flower, pre-rolls, and edibles. Key product launches include:

- Advanced all-in-one vapes with CCELL technology featuring built-in displays for Tweed and 7ACRES brands

- New high-THC flower strains (Sour Sucker Mints and Blood Orange Kush) testing above 28% THC with 3.25-4% total terpenes

- Expanded pre-roll offerings including new Claybourne Frosted Flyers flavors and 7ACRES live resin-infused products

- Deep Space's entry into the edibles category with 10mg THC gummies containing natural caffeine

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.79%
Tags
none
-
Rhea-AI Summary

Canopy Growth (TSX: WEED) (Nasdaq: CGC) has launched Spectrum Reserve, a new premium medical cannabis brand in Canada through its medical division Spectrum Therapeutics. The brand focuses on premium genetics selected for size, potency, and terpene levels.

The program will introduce new strains regularly based on patient feedback, with successful strains remaining in market while others are phased out. The initial release includes four flower strains:

  • Power Plant x Super Silver Haze (Indica, 22-25% THC, 2.21% terpenes)
  • Grape Star x Golden Lemons (Sativa, 22-25% THC, 1.77% terpenes)
  • Malawi x Kosher Tangie (Hybrid, 27-30% THC, 2.59% terpenes)
  • Raspberry Parfait (Sativa-Dominant Hybrid, 22-27% THC, 2.59% terpenes)
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.94%
Tags
none
-
Rhea-AI Summary

Canopy Growth (TSX: WEED, Nasdaq: CGC) has made an optional early prepayment of US$100 million on its senior secured term loan at a discounted price of US$97.5 million. This strategic move will result in annual interest expense savings of approximately US$13 million.

The prepayment, completed under the Term Loan Amendment agreement with senior lenders, extends the loan's maturity date to September 18, 2027. The company had the option to make this Second Prepayment by March 31, 2025.

According to CFO Judy Hong, this action strengthens Canopy's balance sheet by reducing overall debt position and lowering annual interest costs, with no material debt obligations until September 2027.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.09%
Tags
none
Rhea-AI Summary

Wana Brands, North America's leading edibles provider and a subsidiary of Canopy USA , has launched hemp-derived Delta-9 THC gummies in Texas, marking its 22nd state expansion. The product line includes eight varieties of gummies, each containing 20 pieces with 100mg THC and 100mg CBD in different flavors and effects combinations.

The products will be available at select retail locations across major Texas metropolitan areas including Austin, Dallas, and Houston. The product lineup features various formulations under the Balance, Relax, Inspire, and Dream Berry collections, each designed for specific wellness needs.

All products undergo third-party testing for potency, purity, and contaminants. This expansion beyond the Wanderous marketplace represents a strategic move to increase market share through improved product accessibility at local retail locations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.27%
Tags
none

FAQ

What is the current stock price of Canopy Growth (CGC)?

The current stock price of Canopy Growth (CGC) is $1.38 as of April 22, 2026.

What is the market cap of Canopy Growth (CGC)?

The market cap of Canopy Growth (CGC) is approximately 482.0M.